Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilation of portal hypertension
- 1 July 2000
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 119 (1) , 196-200
- https://doi.org/10.1053/gast.2000.8554
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Abnormal regulation of aortic NOS2 and NOS3 activity and expression from portal vein-stenosed rats after lipopolysaccharide administrationHepatology, 1999
- Chronic Blockade of NO Synthase Activity Induces a Proinflammatory Phenotype in the Arterial WallArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- In Vitro Evidence for Vascular Hyporesponsiveness in Clinical and Experimental CirrhosisPharmacology & Therapeutics, 1997
- Nitric oxide-mediated beta 2-adrenoceptor relaxation is impaired in mesenteric veins from portal-hypertensive ratsGastroenterology, 1996
- Hemodynamic changes after ligation of a major branch of the portal vein in rats: Comparison with rats with portal vein constrictionHepatology, 1994
- Early chronic administration of propranolol reduces the severity of portal hypertension and portal-systemic shunts in conscious portal vein stenosed ratsJournal of Hepatology, 1991
- Hyperdynamic circulation in cirrhosis: a role for nitric oxide?The Lancet, 1991
- Increased Portal Venous Resistance Hinders Portal Pressure Reduction During the Administration of β–Adrenergic Blocking Agents in A Portal Hypertensive ModelHepatology, 1985
- Acute effect of propranolol on splanchnic circulation in normal and portal hypertensive ratsJournal of Hepatology, 1985
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976